Novavax, Inc. (NVAX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.13 -3.89%
EPS Growth %: -164.5%
Financial Fact:
Interest income: 554K
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -164.5%
Financial Fact:
Interest income: 554K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $6.68 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
